These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1030 related articles for article (PubMed ID: 34348879)

  • 1. Metabolic syndrome and the risk of COVID-19 infection: A nationwide population-based case-control study.
    Cho DH; Choi J; Gwon JG
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2596-2604. PubMed ID: 34348879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study.
    Kang SH; Cho DH; Choi J; Baik SK; Gwon JG; Kim MY
    PLoS One; 2021; 16(10):e0258229. PubMed ID: 34610052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence and contributing risk factors of coronavirus disease 2019 infection in patients with metabolic syndrome.
    Bagheri-Hosseinabadi Z; Moadab F; Amiri A; Abbasifard M
    BMC Endocr Disord; 2023 May; 23(1):100. PubMed ID: 37142990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome.
    Alur-Gupta S; Boland MR; Dokras A;
    Fertil Steril; 2023 May; 119(5):847-857. PubMed ID: 36693555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study.
    Lee SW; Kim SY; Moon SY; Yang JM; Ha EK; Jee HM; Shin JI; Cho SH; Yon DK; Suh DI
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2262-2271.e2. PubMed ID: 33931377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
    Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
    J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study.
    Yang JM; Koh HY; Moon SY; Yoo IK; Ha EK; You S; Kim SY; Yon DK; Lee SW
    J Allergy Clin Immunol; 2020 Oct; 146(4):790-798. PubMed ID: 32810517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between metabolic syndrome and mortality in patients with COVID-19: A nationwide cohort study.
    Park HJ; Jung JH; Han K; Shin J; Lee Y; Chang Y; Park K; Cho YJ; Choi YS; Kim SM; Nam GE
    Obes Res Clin Pract; 2022; 16(6):484-490. PubMed ID: 36335025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic Health.
    Racine-Brzostek SE; Yang HS; Jack GA; Chen Z; Chadburn A; Ketas TJ; Francomano E; Klasse PJ; Moore JP; McDonough KA; Girardin RC; Dupuis AP; Payne AF; Ma LX; Sweeney J; Zhong E; Yee J; Cushing MM; Zhao Z
    J Clin Endocrinol Metab; 2021 Apr; 106(5):e2025-e2034. PubMed ID: 33524125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.
    Lee SW; Yang JM; Moon SY; Yoo IK; Ha EK; Kim SY; Park UM; Choi S; Lee SH; Ahn YM; Kim JM; Koh HY; Yon DK
    Lancet Psychiatry; 2020 Dec; 7(12):1025-1031. PubMed ID: 32950066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of metabolic syndrome and COVID-19 deterioration.
    Ouedraogo E; Allard L; Bihan H; Goupil de Bouillé J; Giroux-Leprieur B; Sutton A; Baudry C; Josse C; Didier M; Deutsch D; Rezgani I; Bouchaud O; Cosson E
    Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3236-3242. PubMed ID: 34629251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Metabolic Syndrome in the Clinical Outcome of Disease by SARS-COV-2.
    León-Pedroza JI; Rodríguez-Cortés O; Flores-Mejía R; Gaona-Aguas CV; González-Chávez A
    Arch Med Res; 2021 Oct; 52(7):738-745. PubMed ID: 33926762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.
    Denson JL; Gillet AS; Zu Y; Brown M; Pham T; Yoshida Y; Mauvais-Jarvis F; Douglas IS; Moore M; Tea K; Wetherbie A; Stevens R; Lefante J; Shaffer JG; Armaignac DL; Belden KA; Kaufman M; Heavner SF; Danesh VC; Cheruku SR; St Hill CA; Boman K; Deo N; Bansal V; Kumar VK; Walkey AJ; Kashyap R;
    JAMA Netw Open; 2021 Dec; 4(12):e2140568. PubMed ID: 34935924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study.
    Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
    PLoS One; 2018; 13(8):e0202757. PubMed ID: 30142166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid autoimmunity and metabolic syndrome: a nationwide population-based study.
    Kim HJ; Park SJ; Park HK; Byun DW; Suh K; Yoo MH
    Eur J Endocrinol; 2021 Oct; 185(5):707-715. PubMed ID: 34519275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
    Jakob CEM; Borgmann S; Duygu F; Behrends U; Hower M; Merle U; Friedrichs A; Tometten L; Hanses F; Jung N; Rieg S; Wille K; Grüner B; Klinker H; Gersbacher-Runge N; Hellwig K; Eberwein L; Dolff S; Rauschning D; von Bergwelt-Baildon M; Lanznaster J; Strauß R; Trauth J; de With K; Ruethrich M; Lueck C; Nattermann J; Tscharntke L; Pilgram L; Fuhrmann S; Classen A; Stecher M; Schons M; Spinner C; Vehreschild JJ
    Infection; 2021 Feb; 49(1):63-73. PubMed ID: 33001409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and gallstone disease.
    Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
    World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for severity of COVID-19 in hospital patients age 18-29 years.
    Sandoval M; Nguyen DT; Vahidy FS; Graviss EA
    PLoS One; 2021; 16(7):e0255544. PubMed ID: 34329347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching.
    Lee SW; Ha EK; Yeniova AÖ; Moon SY; Kim SY; Koh HY; Yang JM; Jeong SJ; Moon SJ; Cho JY; Yoo IK; Yon DK
    Gut; 2021 Jan; 70(1):76-84. PubMed ID: 32732368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study.
    Fjelltveit EB; Blomberg B; Kuwelker K; Zhou F; Onyango TB; Brokstad KA; Elyanow R; Kaplan IM; Tøndel C; Mohn KGI; Özgümüş T; Cox RJ; Langeland N;
    Clin Infect Dis; 2023 Feb; 76(3):e60-e70. PubMed ID: 35959897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.